I spent years inside the Amazon brand machine. First in M&A, acquiring supplement brands. Then running a €12M P&L, managing a team of analysts and ad operators across dozens of SKUs. I saw the economics from the inside, and one number never stopped bothering me.
A contract manufacturer in Italy produces a magnesium capsule for €2.50. By the time it reaches a consumer on Amazon, it sells for €20. The manufacturer captures 10-15% of that price. The rest goes to a chain of intermediaries whose primary skill is knowing how to operate a Seller Central account and run PPC ads.
The math was never about who deserved the margin. It was about who could afford to reach the consumer.
The marketing team, the ad operators, the customer service desk, the compliance specialists. That infrastructure was expensive, so the value accrued to whoever owned it.
AI changes the equation.
Today, an AI agent can create a product listing in five European languages in hours. It can optimize advertising bids continuously, not in weekly reviews. It can respond to customer inquiries in German, Italian, French, and Spanish simultaneously, at 3 AM, within minutes. It can monitor review sentiment in real-time and generate EFSA-compliant label copy across jurisdictions.
The cost of running a brand is collapsing. The justification for the middleman is collapsing with it.
The cost of running a supplement brand on Amazon is falling from €12,000 per month to under €2,000. Every function that justified the reseller's existence is being absorbed by software. And when marketing execution becomes cheap, the value migrates to whoever controls the product. That's the manufacturer.
The European supplement market is on track to exceed €30 billion by 2030, growing at 7-9% annually, with online channels as the fastest segment. Yet the CDMOs who actually create these products, who hold the formulations, the GMP certifications, the regulatory expertise, capture a fraction of the retail price. That gap is the opportunity.
The manufacturers who move early will capture the margin that's been leaving their factory floor for decades.
Arbi Labs exists to close it. We partner with one CDMO per category and turn their existing, proven, stability-tested formulations into branded products on Amazon. The manufacturer makes the product. Our AI handles brand creation, listings, advertising, customer service, compliance, and demand forecasting. The CDMO earns more per unit than they would selling to a traditional reseller. We earn our share by operating at a fraction of the cost that used to require rooms full of people.
I built Arbi Labs because I saw both sides of this market and realized the middle layer is running out of time.
We're here to make that transition simple.